US FDA nod for Roche’s VENTANA ALK (D5F3) CDx assay as companion diagnostic for NSCLC… EP News Bureau Mar 9, 2021 The VENTANA ALK (D5F3) CDx Assay is now FDA approved as a companion diagnostic in four targeted treatments
